Article Text

67 Development and Validation of a Quality of Life Tool for Patients with Bone Metastases
  1. C Farrington, Specialist Registrar in Palliative Medicine,
  2. G Keenleyside,
  3. E Rogers,
  4. S Kyeremateng and
  5. SH Ahmedzai
  1. Academic Unit of Supportive Care, University of Sheffield, Royal Hallamshire Hospital, Sheffield

Statistics from

Background: Bone metastases are very common in cancer, with an incidence of over 75% in breast and prostate. It is important to be able to determine quantitatively the impact of bone metastases on patients’ lives. The international development of a bone metastases module for the European Organisation for Research and Treatment of Cancer (EORTC) health-related quality of life (HRQoL) modular system 1 is described. Aims: To develop and validate a QoL module for …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.